| Name | Title | Contact Details |
|---|
Olympus delivers the world’s leading-edge nondestructive inspection and measurement solutions by developing tools and technologies that enhance safety, security, quality, and productivity. Our most popular offerings include ultrasound, phased array, microscopy, optical metrology, remote visual inspection, eddy current and XRF and XRD analyzers. We’re looking to share solutions, news, and insights about test, analytical, measurement, and imaging instruments with other industry professionals from the worlds of aerospace, power generation, petrochemical, manufacturing, automotive, consumer products, and many more.
Signify Health exists to drive more healthy, happy days at home. That`s why we`re committed to accelerating the movement to value-based care, transforming how care is paid for and delivered, and sharing accountability for driving better outcomes for the individuals and families we all serve. Today, Signify Health is privileged to impact the lives of millions of people every year. Our high-performance provider and community networks—which includes the nation`s largest field-based network of doctors and nurse practitioners—reaches and engages people anywhere in the U.S. With powerful analytics and clinical expertise, we support individuals` health journeys from the acute care facility to the ideal next site of care and all the way to a place of residence, helping them get home sooner and stay there longer. This is how we`re transforming a fragmented healthcare system into one that`s value-based, human-centered, and drives more healthy and happy days at home.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Consonus Healthcare Services is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MD Anderson has built a worldwide reputation for excellence in cancer patient care, research, education and prevention. We couldn`t have done it without our top-notch faculty and staff, or the generous spirit of volunteers and community members who donate everything from free time to pints of blood to help us in our mission to end cancer. Our various departments work as a team to deliver multidisciplinary cancer care, a concept pioneered by MD Anderson.